These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 10484767)

  • 41. Loss of function effect of RET mutations causing Hirschsprung disease.
    Pasini B; Borrello MG; Greco A; Bongarzone I; Luo Y; Mondellini P; Alberti L; Miranda C; Arighi E; Bocciardi R
    Nat Genet; 1995 May; 10(1):35-40. PubMed ID: 7647787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of Shc docking site on Ret tyrosine kinase.
    Arighi E; Alberti L; Torriti F; Ghizzoni S; Rizzetti MG; Pelicci G; Pasini B; Bongarzone I; Piutti C; Pierotti MA; Borrello MG
    Oncogene; 1997 Feb; 14(7):773-82. PubMed ID: 9047384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Japanese patients with sporadic Hirschsprung: mutation analysis of the receptor tyrosine kinase proto-oncogene, endothelin-B receptor, endothelin-3, glial cell line-derived neurotrophic factor and neurturin genes: a comparison with similar studies.
    Sakai T; Nirasawa Y; Itoh Y; Wakizaka A
    Eur J Pediatr; 2000 Mar; 159(3):160-7. PubMed ID: 10664228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease.
    Borst MJ; VanCamp JM; Peacock ML; Decker RA
    Surgery; 1995 Apr; 117(4):386-91. PubMed ID: 7716719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease.
    Angrist M; Bolk S; Thiel B; Puffenberger EG; Hofstra RM; Buys CH; Cass DT; Chakravarti A
    Hum Mol Genet; 1995 May; 4(5):821-30. PubMed ID: 7633441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of germline GFR alpha-1 mutations in Hirschsprung disease.
    Myers SM; Salomon R; Goessling A; Pelet A; Eng C; von Deimling A; Lyonnet S; Mulligan LM
    J Med Genet; 1999 Mar; 36(3):217-20. PubMed ID: 10204848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines.
    Chappuis-Flament S; Pasini A; De Vita G; Ségouffin-Cariou C; Fusco A; Attié T; Lenoir GM; Santoro M; Billaud M
    Oncogene; 1998 Dec; 17(22):2851-61. PubMed ID: 9879991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Organotypic specificity of key RET adaptor-docking sites in the pathogenesis of neurocristopathies and renal malformations in mice.
    Jain S; Knoten A; Hoshi M; Wang H; Vohra B; Heuckeroth RO; Milbrandt J
    J Clin Invest; 2010 Mar; 120(3):778-90. PubMed ID: 20160347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease.
    Ivanchuk SM; Myers SM; Eng C; Mulligan LM
    Hum Mol Genet; 1996 Dec; 5(12):2023-6. PubMed ID: 8968758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence of RET mutations in patients with Hirschsprung's disease.
    Sancandi M; Ceccherini I; Costa M; Fava M; Chen B; Wu Y; Hofstra R; Laurie T; Griffths M; Burge D; Tam PK
    J Pediatr Surg; 2000 Jan; 35(1):139-42; discussion 142-3. PubMed ID: 10646792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hirschsprung associated GDNF mutations do not prevent RET activation.
    Borghini S; Bocciardi R; Bonardi G; Matera I; Santamaria G; Ravazzolo R; Ceccherini I
    Eur J Hum Genet; 2002 Mar; 10(3):183-7. PubMed ID: 11973622
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules.
    Nakamura T; Komiya M; Gotoh N; Koizumi S; Shibuya M; Mori N
    Oncogene; 2002 Jan; 21(1):22-31. PubMed ID: 11791173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease.
    Bordeaux MC; Forcet C; Granger L; Corset V; Bidaud C; Billaud M; Bredesen DE; Edery P; Mehlen P
    EMBO J; 2000 Aug; 19(15):4056-63. PubMed ID: 10921886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutational analysis of the RET and GDNF gene in children with hypoganglionosis.
    Inoue K; Shimotake T; Tomiyama H; Iwai N
    Eur J Pediatr Surg; 2001 Apr; 11(2):120-3. PubMed ID: 11371032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Variants in RET and IHH Pathway Members in a Large Family With History of Hirschsprung Disease.
    Sribudiani Y; Chauhan RK; Alves MM; Petrova L; Brosens E; Harrison C; Wabbersen T; de Graaf BM; Rügenbrink T; Burzynski G; Brouwer RWW; van IJcken WFJ; Maas SM; de Klein A; Osinga J; Eggen BJL; Burns AJ; Brooks AS; Shepherd IT; Hofstra RMW
    Gastroenterology; 2018 Jul; 155(1):118-129.e6. PubMed ID: 29601828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease.
    Borrego S; Eng C; Sánchez B; Sáez ME; Navarro E; Antiñolo G
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3361-4. PubMed ID: 9745455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells.
    Warner AJ; Lopez-Dee J; Knight EL; Feramisco JR; Prigent SA
    Biochem J; 2000 Apr; 347(Pt 2):501-9. PubMed ID: 10749680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deciphering adaptor specificity in GFL-dependent RET-mediated proliferation and neurite outgrowth.
    Gustin JA; Yang M; Johnson EM; Milbrandt J
    J Neurochem; 2007 Aug; 102(4):1184-94. PubMed ID: 17663753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease.
    Gath R; Goessling A; Keller KM; Koletzko S; Coerdt W; Müntefering H; Wirth S; Hofstra RM; Mulligan L; Eng C; von Deimling A
    Gut; 2001 May; 48(5):671-5. PubMed ID: 11302967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glial cell line-derived neurotrophic factor family receptors are abnormally expressed in aganglionic bowel of a subpopulation of patients with Hirschsprung's disease.
    Lui VC; Samy ET; Sham MH; Mulligan LM; Tam PK
    Lab Invest; 2002 Jun; 82(6):703-12. PubMed ID: 12065680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.